Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.49 USD | -1.02% | -1.19% | -7.75% |
May. 09 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
Apr. 19 | Xenon Pharmaceuticals Inc. Announces Board Resignations | CI |
Financials (USD)
Sales 2024 * | 2.39M | Sales 2025 * | 9.5M | Capitalization | 3.24B |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -260M | EV / Sales 2024 * | 1,120 x |
Net cash position 2024 * | 560M | Net cash position 2025 * | 507M | EV / Sales 2025 * | 288 x |
P/E ratio 2024 * |
-14.5
x | P/E ratio 2025 * |
-12.9
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.16% |
Latest transcript on Xenon Pharmaceuticals Inc.
1 day | -1.02% | ||
1 week | -1.19% | ||
Current month | +4.53% | ||
1 month | -1.25% | ||
3 months | -15.09% | ||
6 months | +41.63% | ||
Current year | -7.75% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03-09-30 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 0 M€ | -5.02% | ||
0.22% | 0 M€ | 0.00% | - | |
0.22% | 0 M€ | 0.00% | - | |
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 42.93 | -1.15% | 113,596 |
24-05-07 | 43.43 | +0.56% | 140,345 |
24-05-06 | 43.19 | -1.28% | 266,970 |
24-05-03 | 43.75 | +1.74% | 252,216 |
24-05-02 | 43 | +1.20% | 204,121 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.75% | 3.24B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- XENE Stock